Atomic Magnetometer Brain Imaging for Epilepsy
Trial Summary
What is the purpose of this trial?
This study is being done to help scientists learn about the use of a device called an atomic magnetometer. The device uses sensors called optically-pumped magnetometers (OPM) which function at room temperature. This research will compare the non-invasive brain imaging application of the OPM sensors to the present SQUID-based cryogenic sensor technique used in conventional Magnetoencephalography (MEG). This study is being conducted in conjunction with the University of Colorado Boulder's Mechanical Engineering Department.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment OPM sensors, Optically Pumped Magnetometers, Room Temperature Atomic Magnetometers, SQUID sensors, Superconducting Quantum Interference Devices for epilepsy?
Research shows that optically pumped magnetometers (OPMs) can detect epileptic brain activity with a better signal-to-noise ratio than traditional SQUID sensors, making them a promising tool for epilepsy diagnosis and management. OPMs are also wearable and more affordable, allowing for easier and more widespread use in clinical settings, especially for children and patients with movement during seizures.12345
Is the use of atomic magnetometers for brain imaging safe for humans?
Research on optically pumped magnetometers (OPMs) for brain imaging, such as magnetoencephalography (MEG), suggests they are safe for human use. These devices are non-invasive, operate at room temperature, and do not require the cryogenic cooling needed for traditional SQUID sensors, reducing potential risks associated with extreme temperatures.678910
How does the Atomic Magnetometer Brain Imaging treatment for epilepsy differ from other treatments?
This treatment uses optically pumped atomic magnetometers (OPAMs) to detect magnetic fields in the brain, offering a non-invasive and room-temperature alternative to traditional superconducting devices that require expensive cryogenic cooling. It provides high-resolution imaging of epileptic events, similar in size and flexibility to EEG electrodes, making it more practical for long-term monitoring of seizures.5691112
Eligibility Criteria
This trial is for adults aged 18-70 with epilepsy, referred through the clinical MEG program. It's not for pregnant women, those unable to consent, people with neurological disorders other than epilepsy or who can't lie still during recording, and anyone with metal implants that could interfere with sensor readings.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Device Testing
Participants undergo non-invasive brain imaging using OPM and SQUID sensors to compare their effectiveness
Follow-up
Participants are monitored for any adverse effects and the effectiveness of the imaging techniques is evaluated
Treatment Details
Interventions
- OPM sensors
- SQUID sensors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
University of Colorado, Boulder
Collaborator